AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
55,000
Employees55,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
55,000
Employees55,000

ABBV Key Statistics

Market cap
408.63B
Market cap408.63B
Price-Earnings ratio
110.80
Price-Earnings ratio110.80
Dividend yield
2.78%
Dividend yield2.78%
Average volume
7.38M
Average volume7.38M
High today
$233.38
High today$233.38
Low today
$230.50
Low today$230.50
Open price
$231.75
Open price$231.75
Volume
300.06K
Volume300.06K
52 Week high
$244.81
52 Week high$244.81
52 Week low
$163.81
52 Week low$163.81

ABBV News

Benzinga 2d
AbbVie's Botox Shows Improvement In Movement Disorder Study

AbbVie Inc. (NYSE:ABBV) on Monday shared topline results from the Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) compared to placebo for upper limb e...

AbbVie's Botox Shows Improvement In Movement Disorder Study
Seeking Alpha 2d
AbbVie succeeds in mid-stage study of neurological disease treatment

AbbVie (NYSE:ABBV) announced that its mid-stage study of Botox (onabotulinumtoxinA) for treating essential tremor in the upper limbs achieved its main goal. Th...

AbbVie succeeds in mid-stage study of neurological disease treatment
TipRanks 2d
AbbVie reports ‘positive’ results from Phase 2 ELATE trial

AbbVie (ABBV) announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA compared to placebo for t...

Analyst ratings

61%

of 31 ratings
Buy
61.3%
Hold
35.5%
Sell
3.2%

More ABBV News

Simply Wall St 3d
Will AbbVie’s US Biologics Bet Reinforce Its Competitive Edge in Oncology?

AbbVie recently submitted a Biologics License Application to the FDA for pivekimab sunirine, an investigational therapy targeting rare blood cancers, and began...

Will AbbVie’s US Biologics Bet Reinforce Its Competitive Edge in Oncology?
Nasdaq 3d
Guru Fundamental Report for ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model ba...

Guru Fundamental Report for ABBV
24/7 Wall St. 4d
AbbVie, General Dynamics, and Ruger Deliver Strong 2025 Returns With Dividend Yields

Home Investing Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR) Investing Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV...

AbbVie, General Dynamics, and Ruger Deliver Strong 2025 Returns With Dividend Yields
TipRanks 5d
AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense

In a regulatory filing, the company stated, “Reported GAAP earnings and adjusted non-GAAP earnings for the third quarter of 2025 are expected to include acquire...

The Motley Fool 5d
St Louis Financial Loads Up on AbbVie With 14,600 Shares Buy

St. Louis Financial Planners Asset Management, LLC initiated a new stake in AbbVie (ABBV -0.85%), acquiring 14,630 shares for an estimated $3.39 million in Q3 2...

St Louis Financial Loads Up on AbbVie With 14,600 Shares Buy
TipRanks 6d
AbbVie’s Phase 2 HIV Study Completion: Potential Market Impact

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powe...

TipRanks 6d
AbbVie Completes Key Study on ABBV-101’s Food Interaction

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock po...

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.